Literature DB >> 16455481

Proteins with whey-acidic-protein motifs and cancer.

Dominique Bouchard1, Dany Morisset, Yves Bourbonnais, Guy M Tremblay.   

Abstract

The importance of early diagnosis to reduce the morbidity and mortality from cancer has led to a search for new sensitive and specific tumour markers. Molecular techniques developed over the past few years allow simultaneous screening of thousands of genes, and have been applied to different cancers to identify many genes that are modulated in various cancers. Of these, attention has focused on genes coding for a family of proteins with whey-acidic-protein (WAP) motifs. Most notably, the genes coding for elafin, antileukoproteinase 1 (previously called secretory leucocyte proteinase inhibitor, SLPI), WAP four disulphide core domain protein 1 (previously called prostate stromal protein 20 kDa, PS20), and WAP four disulphide core domain protein 2 (previously called major human epididymis-specific protein E4, HE4), have been identified as candidate molecular markers for several cancers. In this review, we assess data for an association between cancer and human WAP proteins, and discuss their potential role in tumour progression. We also propose a new mechanism by which WAP proteins might have a role in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455481     DOI: 10.1016/S1470-2045(06)70579-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  67 in total

1.  Splice variant HE4-V3 expression is associated with favorable prognosis in pulmonary adenocarcinoma.

Authors:  Keita Tokuishi; Shin-ichi Yamashita; Kazuyuki Ohbo; Katsunobu Kawahara
Journal:  Tumour Biol       Date:  2011-10-21

Review 2.  Molecular signatures of ovarian cancer: from detection to prognosis.

Authors:  Christine S Walsh; Beth Y Karlan
Journal:  Mol Diagn Ther       Date:  2010-02-01       Impact factor: 4.074

3.  Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.

Authors:  Q-L Li; C-J Wang; P Qi; Y-X Zhang
Journal:  Clin Transl Oncol       Date:  2017-04-25       Impact factor: 3.405

4.  Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer.

Authors:  Jung H Kim; Saravana M Dhanasekaran; John R Prensner; Xuhong Cao; Daniel Robinson; Shanker Kalyana-Sundaram; Christina Huang; Sunita Shankar; Xiaojun Jing; Matthew Iyer; Ming Hu; Lee Sam; Catherine Grasso; Christopher A Maher; Nallasivam Palanisamy; Rohit Mehra; Hal D Kominsky; Javed Siddiqui; Jindan Yu; Zhaohui S Qin; Arul M Chinnaiyan
Journal:  Genome Res       Date:  2011-07       Impact factor: 9.043

5.  Elafin selectively regulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis.

Authors:  Huafeng Wei; Karl Erik Hellström; Ingegerd Hellström
Journal:  Gynecol Oncol       Date:  2012-03-16       Impact factor: 5.482

6.  Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.

Authors:  Eleftheria Kalogera; Nathalie Scholler; Cecelia Powless; Amy Weaver; Ronny Drapkin; Jinping Li; Shi-Wen Jiang; Karl Podratz; Nicole Urban; Sean C Dowdy
Journal:  Gynecol Oncol       Date:  2011-10-28       Impact factor: 5.482

7.  Secretory leukocyte protease inhibitor (SLPI) expression and tumor invasion in oral squamous cell carcinoma.

Authors:  Jie Wen; Nikolaos G Nikitakis; Risa Chaisuparat; Teresa Greenwell-Wild; Maria Gliozzi; Wenwen Jin; Azita Adli; Niki Moutsopoulos; Tanxia Wu; Gary Warburton; Sharon M Wahl
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

8.  A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass.

Authors:  Richard G Moore; D Scott McMeekin; Amy K Brown; Paul DiSilvestro; M Craig Miller; W Jeffrey Allard; Walter Gajewski; Robert Kurman; Robert C Bast; Steven J Skates
Journal:  Gynecol Oncol       Date:  2008-10-12       Impact factor: 5.482

Review 9.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

10.  Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression.

Authors:  Shin-ichi Yamashita; Keita Tokuishi; Toshihiko Moroga; Satoshi Yamamoto; Kazuyuki Ohbo; So Miyahara; Yasuhiro Yoshida; Jun Yanagisawa; Daisuke Hamatake; Masafumi Hiratsuka; Yasuteru Yoshinaga; Takeshi Shiraishi; Akinori Iwasaki; Katsunobu Kawahara
Journal:  Tumour Biol       Date:  2012-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.